{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:29:15Z","timestamp":1786768155659,"version":"build-2736575974"},"reference-count":96,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Pendleton Laboratory Fund for Pediatric Infectious Disease Research"},{"name":"Manning Fund for COVID-19 Research at the University of Virginia"},{"DOI":"10.13039\/100008222","name":"Ivy Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008222","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/057rnbw54","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Coulter Foundation"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases (NIAID), NIH","doi-asserted-by":"crossref","award":["R01 AI176515"],"award-info":[{"award-number":["R01 AI176515"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"award":["R01 AI176515"],"award-info":[{"award-number":["R01 AI176515"]}],"id":[{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"publisher"}]},{"name":"NIAID\u2013Duke University contract","award":["75N93025C00006"],"award-info":[{"award-number":["75N93025C00006"]}]},{"name":"United States Department of Agriculture (USDA) National Institute of Food and Agriculture","award":["2025-67015-44993"],"award-info":[{"award-number":["2025-67015-44993"]}]},{"award":["2025-67015-44993"],"award-info":[{"award-number":["2025-67015-44993"]}],"id":[{"id":"https:\/\/ror.org\/05qx3fv49","id-type":"ROR","asserted-by":"publisher"}]},{"name":"University of Virginia Flow Cytometry Core Facility","award":["RRID:SCR_017829"],"award-info":[{"award-number":["RRID:SCR_017829"]}]},{"name":"National Cancer Institute","award":["P30-CA044579"],"award-info":[{"award-number":["P30-CA044579"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Background: Trimeric envelope-proximal domains in viral class I fusion proteins are conserved targets of broadly neutralizing antibodies (bNAbs), but it has proven difficult to develop vaccines against those targets. The HIV-1 gp41 membrane-proximal external region (MPER) is one such target. Induction of a neutralizing response likely depends on the immunogen having a close-to-native structure. Methods: Native sequence MPER was displayed on genome-reduced bacteria as a coiled-coil homotrimer using a Haemophilus influenzae Hia trimeric autotransporter. Vaccine designs incorporated additional features, including trimerization domains to stabilize MPER, tandem MPER repeats to increase antigen valency, and immunomodulatory elements. Antigen exposure was assessed by flow cytometry, antibody responses were evaluated by ELISA, and functional activity was measured using HIV-1 pseudovirus neutralization assays. Results: Trimer stabilization improved MPER exposure, but immunogen visibility alone did not predict neutralization. After three immunizations, neutralizing activity was detected only in the most extensively engineered vaccine, which neutralized tier 2 virus CNE55. After five immunizations, the same vaccine also neutralized the tier 2 virus 25710-2.43. A further design modification that included an extended Hia-derived spacer increased MPER exposure and antibody binding, with neutralization detected against MN.3, X1632_S2_B10, and 25710-2.43 viruses in subsets of animals. Conclusions: As a proof-of-concept, native-sequence MPER can induce detectable, though modest and virus-dependent, HIV-1 neutralizing activity when displayed in a carefully controlled trimeric bacterial surface-display platform. The results show that MPER vaccine performance depends not only on antigen exposure, but also on multimeric organization, immunomodulatory context, and antigen-scaffold geometry. Analogous coiled-coil trimeric bacterial surface display immunogens may inform vaccine development for stem\/stalk regions of other Class I fusion protein viruses.<\/jats:p>","DOI":"10.3390\/v18080890","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:06:16Z","timestamp":1786608376000},"page":"890","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trimeric Class I Viral Fusion Protein Vaccine Immunogens Using a Trimeric Autotransporter in a Killed Whole-Cell Bacteria Vaccine Platform: Applications to HIV MPER"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8020-5265","authenticated-orcid":false,"given":"Juan Sebastian","family":"Quintero-Barbosa","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Virginia, Charlottesville, VA 22908, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Virginia, Charlottesville, VA 22908, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9929-3185","authenticated-orcid":false,"given":"Frances","family":"Mehl","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Virginia, Charlottesville, VA 22908, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5616-0877","authenticated-orcid":false,"given":"Shubham","family":"Mathur","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Virginia, Charlottesville, VA 22908, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9261-6394","authenticated-orcid":false,"given":"Lauren","family":"Livingston","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Virginia, Charlottesville, VA 22908, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8387-3952","authenticated-orcid":false,"given":"Xiaoying","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Duke University, Durham, NC 27710, USA"},{"name":"Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Montefiori","sequence":"additional","affiliation":[{"name":"Department of Surgery, Duke University, Durham, NC 27710, USA"},{"name":"Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Zeichner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Virginia, Charlottesville, VA 22908, USA"},{"name":"Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-cellbio-101512-122422","article-title":"Virus and Cell Fusion Mechanisms","volume":"30","author":"Podbilewicz","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"13133","DOI":"10.1073\/pnas.1414070111","article-title":"Induction of Broadly Cross-Reactive Antibody Responses to the Influenza HA Stem Region Following H5N1 Vaccination in Humans","volume":"111","author":"Ellebedy","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"13260","DOI":"10.1128\/JVI.02133-14","article-title":"Induction of Broadly Reactive Anti-Hemagglutinin Stalk Antibodies by an H5N1 Vaccine in Humans","volume":"88","author":"Nachbagauer","year":"2014","journal-title":"J. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e01463-17","DOI":"10.1128\/mBio.01463-17","article-title":"Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum Are a Surrogate Marker for in vivo Protection in a Serum Transfer Mouse Challenge Model","volume":"8","author":"Jacobsen","year":"2017","journal-title":"MBio"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e02249-17","DOI":"10.1128\/JVI.02249-17","article-title":"Functional Optimization of Broadly Neutralizing HIV-1 Antibody 10E8 by Promotion of Membrane Interactions","volume":"92","author":"Rujas","year":"2018","journal-title":"J. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/01.aids.0000189850.83322.41","article-title":"The Membrane-Proximal External Region of HIV-1 Gp41: A Vaccine Target Worth Exploring","volume":"19","author":"Zwick","year":"2005","journal-title":"AIDS"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Buzon, V., Natrajan, G., Schibli, D., Campelo, F., Kozlov, M.M., and Weissenhorn, W. (2010). Crystal Structure of HIV-1 Gp41 Including Both Fusion Peptide and Membrane Proximal External Regions. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1000880"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Boomgarden, A.C., and Upadhyay, C. (2025). Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview. Vaccines, 13.","DOI":"10.3390\/vaccines13020148"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev-immunol-041015-055515","article-title":"Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design","volume":"34","author":"Burton","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nature07352","article-title":"Challenges in the Development of an HIV-1 Vaccine","volume":"455","author":"Barouch","year":"2008","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s13238-018-0534-7","article-title":"The Development of HIV Vaccines Targeting Gp41 Membrane-Proximal External Region (MPER): Challenges and Prospects","volume":"9","author":"Liu","year":"2018","journal-title":"Protein Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.chom.2019.09.016","article-title":"Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01","volume":"26","author":"Pinto","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"107583","DOI":"10.1016\/j.celrep.2020.107583","article-title":"HIV-1 Envelope and MPER Antibody Structures in Lipid Assemblies","volume":"31","author":"Rantalainen","year":"2020","journal-title":"Cell Rep."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Shim, I., Rogowski, L., and Venketaraman, V. (2025). Progress and Recent Developments in HIV Vaccine Research. Vaccines, 13.","DOI":"10.3390\/vaccines13070690"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/COH.0b013e32833d17ac","article-title":"HIV Vaccines\u2014Lessons Learned and the Way Forward","volume":"5","author":"Kim","year":"2010","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1016\/j.celrep.2017.12.028","article-title":"Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models","volume":"21","author":"Saunders","year":"2017","journal-title":"Cell Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"aab1253","DOI":"10.1126\/science.aab1253","article-title":"Diversion of HIV-1 Vaccine\u2013Induced Immunity by Gp41-Microbiota Cross-Reactive Antibodies","volume":"349","author":"Williams","year":"2015","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"336ra62","DOI":"10.1126\/scitranslmed.aaf0618","article-title":"Initiation of Immune Tolerance\u2013Controlled HIV Gp41 Neutralizing B Cell Lineages","volume":"8","author":"Zhang","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41590-024-01833-w","article-title":"Vaccination Induces Broadly Neutralizing Antibody Precursors to HIV Gp41","volume":"25","author":"Schiffner","year":"2024","journal-title":"Nat. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Molinos-Albert, L.M., Clotet, B., Blanco, J., and Carrillo, J. (2017). Immunologic Insights on the Membrane Proximal External Region: A Major Human Immunodeficiency Virus Type-1 Vaccine Target. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01154"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1021\/acs.molpharmaceut.4c01341","article-title":"Distinctive Membrane Accommodation Traits Underpinning the Neutralization Activity of HIV-1 Antibody against MPER","volume":"22","author":"Domene","year":"2025","journal-title":"Mol. Pharm."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"12501","DOI":"10.1128\/JVI.02097-15","article-title":"Bispecific Antibodies Targeting Different Epitopes on the HIV-1 Envelope Exhibit Broad and Potent Neutralization","volume":"89","author":"Asokan","year":"2015","journal-title":"J. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1128\/JVI.02380-15","article-title":"Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody","volume":"90","author":"Cheng","year":"2016","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Cheng, C., Xu, K., Kong, R., Chuang, G.-Y., Corrigan, A.R., Geng, H., Hill, K.R., Jafari, A.J., O\u2019Dell, S., and Ou, L. (2019). Consistent Elicitation of Cross-Clade HIV-Neutralizing Responses Achieved in Guinea Pigs after Fusion Peptide Priming by Repetitive Envelope Trimer Boosting. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0215163"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0005-2736(03)00169-X","article-title":"Fusion Peptides and the Mechanism of Viral Fusion","volume":"1614","author":"Epand","year":"2003","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Biomembr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.cell.2015.11.056","article-title":"Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-Neutralizing Epitopes","volume":"163","author":"Ozorowski","year":"2015","journal-title":"Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1074\/jbc.M112.424432","article-title":"Designing a Soluble near Full-Length HIV-1 Gp41 Trimer","volume":"288","author":"Gao","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/COH.0000000000000363","article-title":"Stabilized HIV-1 Envelope Glycoprotein Trimers for Vaccine Use","volume":"12","author":"Sanders","year":"2017","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1126\/science.1254426","article-title":"Conformational Dynamics of Single HIV-1 Envelope Trimers on the Surface of Native Virions","volume":"346","author":"Munro","year":"2014","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"22666","DOI":"10.1038\/srep22666","article-title":"Stalking Influenza by Vaccination with Pre-Fusion Headless HA Mini-Stem","volume":"6","author":"Valkenburg","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41594-021-00596-4","article-title":"Structural Basis for Broad Coronavirus Neutralization","volume":"28","author":"Sauer","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e2025622118","DOI":"10.1073\/pnas.2025622118","article-title":"Killed Whole-Genome Reduced-Bacteria Surface-Expressed Coronavirus Fusion Peptide Vaccines Protect against Disease in a Porcine Model","volume":"118","author":"Maeda","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Quintero-Barbosa, J.S., Song, Y., Mehl, F., Mathur, S., Livingston, L., Shen, X., Montefiori, D.C., Tan, J., and Zeichner, S.L. (2025). Engineering Enhanced Immunogenicity of Surface-Displayed Immunogens in a Killed Whole-Cell Genome-Reduced Bacterial Vaccine Platform Using Class I Viral Fusion Peptides. Vaccines, 14.","DOI":"10.3390\/vaccines14010014"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Quintero-Barbosa, J.S., Song, Y., Mehl, F., Mathur, S., Livingston, L., Kwong, P.D., Shen, X., Montefiori, D.C., and Zeichner, S.L. (2026). HIV Membrane-Proximal External Region Scaffolded Immunogen as Killed Whole-Cell Genome-Reduced Vaccines. Viruses, 18.","DOI":"10.20944\/preprints202601.1036.v1"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0966-842X(98)01318-3","article-title":"The Great Escape: Structure and Function of the Autotransporter Proteins","volume":"6","author":"Henderson","year":"1998","journal-title":"Trends Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1128\/MMBR.68.4.692-744.2004","article-title":"Type V Protein Secretion Pathway: The Autotransporter Story","volume":"68","author":"Henderson","year":"2004","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijmm.2011.03.003","article-title":"Structures and Functions of Autotransporter Proteins in Microbial Pathogens","volume":"301","author":"Benz","year":"2011","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1128\/JB.00164-06","article-title":"Trimeric Autotransporters Require Trimerization of the Passenger Domain for Stability and Adhesive Activity","volume":"188","author":"Cotter","year":"2006","journal-title":"J. Bacteriol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0966-842X(00)01853-9","article-title":"Autotransporter Proteins, Evolution and Redefining Protein Secretion","volume":"8","author":"Henderson","year":"2000","journal-title":"Trends Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/1040841X.2013.804032","article-title":"Autotransporter-Based Cell Surface Display in Gram-Negative Bacteria","volume":"41","author":"Nicolay","year":"2015","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1128\/JB.185.18.5585-5590.2003","article-title":"Autotransporters as Scaffolds for Novel Bacterial Adhesins: Surface Properties of Escherichia Coli Cells Displaying Jun\/Fos Dimerization Domains","volume":"185","author":"Veiga","year":"2003","journal-title":"J. Bacteriol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/sj.emboj.7601132","article-title":"Structure of the Outer Membrane Translocator Domain of the Haemophilus Influenzae Hia Trimeric Autotransporter","volume":"25","author":"Meng","year":"2006","journal-title":"EMBO J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"14679","DOI":"10.1074\/jbc.M311496200","article-title":"The Haemophilus Influenzae Hia Autotransporter Contains an Unusually Short Trimeric Translocator Domain","volume":"279","author":"Surana","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/371080a0","article-title":"Crystal Structure of an Isoleucine-Zipper Trimer","volume":"371","author":"Harbury","year":"1994","journal-title":"Nature"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jmb.2004.09.079","article-title":"Foldon, the Natural Trimerization Domain of T4 Fibritin, Dissociates into a Monomeric A-State Form Containing a Stable Beta-Hairpin: Atomic Details of Trimer Dissociation and Local Beta-Hairpin Stability from Residual Dipolar Couplings","volume":"344","author":"Meier","year":"2004","journal-title":"J. Mol. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/infdis\/jis107","article-title":"Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines with or Without PF03512676 Adjuvant","volume":"205","author":"Longmate","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0264-410X(97)00186-2","article-title":"Potent Immunogenic Short Linear Peptide Constructs Composed of B Cell Epitopes and Pan DR T Helper Epitopes (PADRE) for Antibody Responses in vivo","volume":"15","author":"Alexander","year":"1997","journal-title":"Vaccine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.4049\/jimmunol.164.3.1625","article-title":"Linear PADRE T Helper Epitope and Carbohydrate B Cell Epitope Conjugates Induce Specific High Titer IgG Antibody Responses1","volume":"164","author":"Alexander","year":"2000","journal-title":"J. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Diaz-Dinamarca, D.A., Manzo, R.A., Soto, D.A., Avenda\u00f1o-Valenzuela, M.J., Bastias, D.N., Soto, P.I., Escobar, D.F., Vasquez-Saez, V., Carri\u00f3n, F., and Pizarro-Ortega, M.S. (2020). Surface Immunogenic Protein of Streptococcus Group B Is an Agonist of Toll-Like Receptors 2 and 4 and a Potential Immune Adjuvant. Vaccines, 8.","DOI":"10.3390\/vaccines8010029"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Dinamarca, D.A., Salazar, M.L., Castillo, B.N., Manubens, A., Vasquez, A.E., Salazar, F., and Becker, M.I. (2022). Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081671"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly Accurate Protein Structure Prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"btad424","DOI":"10.1093\/bioinformatics\/btad424","article-title":"Evaluation of AlphaFold-Multimer Prediction on Multi-Chain Protein Complexes","volume":"39","author":"Zhu","year":"2023","journal-title":"Bioinformatics"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","article-title":"UCSF ChimeraX: Meeting Modern Challenges in Visualization and Analysis","volume":"27","author":"Goddard","year":"2018","journal-title":"Protein Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e4792","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: Tools for Structure Building and Analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure Visualization for Researchers, Educators, and Developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2958.2004.04386.x","article-title":"Cell Size and Nucleoid Organization of Engineered Escherichia Coli Cells with a Reduced Genome","volume":"55","author":"Hashimoto","year":"2005","journal-title":"Mol. Microbiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/msb4100174","article-title":"Construction of Consecutive Deletions of the Escherichia Coli Chromosome","volume":"3","author":"Kato","year":"2007","journal-title":"Mol. Syst. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1128\/JVI.02108-09","article-title":"Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies","volume":"84","author":"Seaman","year":"2010","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Prasad, V.R., and Kalpana, G.V. (2009). Measuring HIV Neutralization in a Luciferase Reporter Gene Assay. HIV Protocols, Humana Press.","DOI":"10.1007\/978-1-59745-170-3"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/313277a0","article-title":"Complete Nucleotide Sequence of the AIDS Virus, HTLV-III","volume":"313","author":"Ratner","year":"1985","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine Delivery: A Matter of Size, Geometry, Kinetics and Molecular Patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"12663","DOI":"10.1038\/s41598-021-92280-2","article-title":"Nanoscale Spatial Dependence of Avidity in an IgG1 Antibody","volume":"11","author":"Jendroszek","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/s41590-023-01597-9","article-title":"Molecular Basis for Potent B Cell Responses to Antigen Displayed on Particles of Viral Size","volume":"24","author":"Brooks","year":"2023","journal-title":"Nat. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular Helper CD4 T Cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","article-title":"Germinal Centers","volume":"30","author":"Victora","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature12966","article-title":"Proof of Principle for Epitope-Focused Vaccine Design","volume":"507","author":"Correia","year":"2014","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"11265","DOI":"10.1128\/JVI.01359-09","article-title":"Broad HIV-1 Neutralization Mediated by Plasma Antibodies against the Gp41 Membrane Proximal External Region","volume":"83","author":"Gray","year":"2009","journal-title":"J. Virol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.1038\/s41467-023-42097-6","article-title":"Inadequate Structural Constraint on Fab Approach Rather than Paratope Elicitation Limits HIV-1 MPER Vaccine Utility","volume":"14","author":"Tan","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s10439-019-02398-8","article-title":"An Engineered Biomimetic MPER Peptide Vaccine Induces Weakly HIV Neutralizing Antibodies in Mice","volume":"48","author":"Shao","year":"2020","journal-title":"Ann. Biomed. Eng."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Zhou, T., Zhu, J., Yang, Y., Gorman, J., Ofek, G., Srivatsan, S., Druz, A., Lees, C.R., Lu, G., and Soto, C. (2014). Transplanting Supersites of HIV-1 Vulnerability. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0099881"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.vaccine.2014.12.045","article-title":"Liposomal Vaccines Incorporating Molecular Adjuvants and Intrastructural T-Cell Help Promote the Immunogenicity of HIV Membrane-Proximal External Region Peptides","volume":"33","author":"Hanson","year":"2015","journal-title":"Vaccine"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.virol.2009.05.015","article-title":"Characterization of a Trimeric MPER Containing HIV-1 Gp41 Antigen","volume":"390","author":"Hinz","year":"2009","journal-title":"Virology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.virol.2015.09.010","article-title":"Immunogenic Properties of a Trimeric Gp41-Based Immunogen Containing an Exposed Membrane-Proximal External Region","volume":"486","author":"Habte","year":"2015","journal-title":"Virology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1747-0285.2012.01423.x","article-title":"Conformation-specific Display of 4E10 and 2F5 Epitopes on Self-assembling Protein Nanoparticles as a Potential HIV Vaccine","volume":"80","author":"Wahome","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2014.04.009","article-title":"Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of Gp41 on Cleaved Envelope Trimers","volume":"40","author":"Falkowska","year":"2014","journal-title":"Immunity"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature13808","article-title":"Structure and Immune Recognition of Trimeric Pre-Fusion HIV-1 Env","volume":"514","author":"Pancera","year":"2014","journal-title":"Nature"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1128\/JVI.03187-14","article-title":"Structure and Dynamics of the Native HIV-1 Env Trimer","volume":"89","author":"Munro","year":"2015","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Sanders, R.W., Derking, R., Cupo, A., Julien, J.-P., Yasmeen, A., De Val, N., Kim, H.J., Blattner, C., De La Pe\u00f1a, A.T., and Korzun, J. (2013). A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 Gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003618"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.it.2016.01.007","article-title":"HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies","volume":"37","author":"Moore","year":"2016","journal-title":"Trends Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1128\/JVI.75.22.10892-10905.2001","article-title":"Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein Gp41","volume":"75","author":"Zwick","year":"2001","journal-title":"J. Virol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Gustchina, E., Li, M., Louis, J.M., Anderson, D.E., Lloyd, J., Frisch, C., Bewley, C.A., Gustchina, A., Wlodawer, A., and Clore, G.M. (2010). Structural Basis of HIV-1 Neutralization by Affinity Matured Fabs Directed against the Internal Trimeric Coiled-Coil of Gp41. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001182"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"11975","DOI":"10.1128\/JVI.01793-15","article-title":"Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10","volume":"89","author":"Rujas","year":"2015","journal-title":"J. Virol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41579-025-01206-6","article-title":"The HIV-1 Envelope Glycoprotein: Structure, Function and Interactions with Neutralizing Antibodies","volume":"23","author":"Klasse","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Guenaga, J., Dosenovic, P., Ofek, G., Baker, D., Schief, W.R., Kwong, P.D., Karlsson Hedestam, G.B., and Wyatt, R.T. (2011). Heterologous Epitope-Scaffold Prime:Boosting Immuno-Focuses B Cell Responses to the HIV-1 Gp41 2F5 Neutralization Determinant. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016074"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12977-015-0210-4","article-title":"Presenting Native-like HIV-1 Envelope Trimers on Ferritin Nanoparticles Improves Their Immunogenicity","volume":"12","author":"Sliepen","year":"2015","journal-title":"Retrovirology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/s41467-019-10262-5","article-title":"Structure and Immunogenicity of a Stabilized HIV-1 Envelope Trimer Based on a Group-M Consensus Sequence","volume":"10","author":"Sliepen","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.chom.2019.04.011","article-title":"Conformational Plasticity in the HIV-1 Fusion Peptide Facilitates Recognition by Broadly Neutralizing Antibodies","volume":"25","author":"Yuan","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1038\/ncomms9167","article-title":"Antibodies to a Conformational Epitope on Gp41 Neutralize HIV-1 by Destabilizing the Env Spike","volume":"6","author":"Lee","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.cell.2016.08.005","article-title":"Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies","volume":"166","author":"Briney","year":"2016","journal-title":"Cell"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.cell.2016.07.030","article-title":"Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice","volume":"166","author":"Escolano","year":"2016","journal-title":"Cell"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"101003","DOI":"10.1016\/j.xcrm.2023.101003","article-title":"Germline-Targeting HIV-1 Env Vaccination Induces VRC01-Class Antibodies with Rare Insertions","volume":"4","author":"Caniels","year":"2023","journal-title":"Cell Rep. Med."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Huang, J., Swanson, O.M., Rantalainen, K., Fernandez-Quintero, M.L., Loeffler, J.R., Tingle, R., Georgeson, E., Phelps, N., Ozorowski, G., and Schiffner, T. (2025). CryoEM Structures of Antibodies Elicited by Germline-Targeting HIV MPER Epitope-Scaffolds. bioRxiv.","DOI":"10.1101\/2025.08.19.671101"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.str.2010.06.010","article-title":"Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope","volume":"18","author":"Correia","year":"2010","journal-title":"Structure"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMp2415893","article-title":"An HIV Vaccine in the Era of Twice-Yearly Lenacapavir for PrEP\u2014Essential or Irrelevant?","volume":"392","author":"Jatt","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"S549","DOI":"10.1093\/cid\/ciac752","article-title":"Barriers to Uptake of Long-Acting Antiretroviral Products for Treatment and Prevention of HIV in Low- and Middle-Income Countries (LMICs)","volume":"75","author":"Kityo","year":"2022","journal-title":"Clin. Infect. Dis."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/8\/890\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:16:11Z","timestamp":1786767371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/8\/890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":96,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["v18080890"],"URL":"https:\/\/doi.org\/10.3390\/v18080890","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]}}}